Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-35
SponsorWashington State University

About this trial

The overarching goal of this study is to develop and examine the feasibility of a music-listening intervention that can be deployed in "real time" to regulate emotions and reduce momentary stress among young adults within the first 12 months of recovery from alcohol use disorder. We design the study with two phases to address three aims: Phase I includes the first two aims. For Aim 1, we will conduct formative research with a sample of young adults (N = 30) who have are within 12 months of recovery to identify features of music selections that are most effective in reducing momentary stress in real-world, ambulatory settings. For Aim 2, we will focus on developing mobile health technology that uses passive sensing and machine learning to automatically predict moments of heightened stress in real-time and suggest specific musical selections when stress is detected. During Phase II (Aim 3), we will test the feasibility of a novel music-listening intervention among a second unique sample of young adults who are within 12 months of recovery from AUD (N = 30). This protocol refers only to Phase I of the larger study, which focuses on observing music listening preferences and physiological and mental stress among people in early recovery from alcohol use disorder.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject can and has signed an Institutional Review Board (IRB) approved informed consent form (ICF).

Age ≥18 and ≤35 years.

In early-stage recovery for alcohol use (within 12 months)

Own a smartphone with a data plan

Disqualifiers

Currently experiencing symptoms of severe depression

Currently experiencing thoughts of suicide

Currently taking medication treatment for opioid use disorder (OUD)

Are unable to provide voluntary informed consent.

Trial population

Participants will recruited from behavioral health clinics and the general Spokane, WA community.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

30 Participants
are grouped into 1 trial group
Group A: Cohort 1

Trial outcomes

Primary outcomes

1

Electrodermal Activity (EDA)

EDA will be assessed via a research-level wearable sensor (Empatica EmbracePlus) that will collect continuous physiological data

Time frame
14 days
2

Heart Rate Variability (HRV)

HRV will be assessed via a research-level wearable sensor (Empatica EmbracePlus) that will collect continuous physiological data

Time frame
14 days
3

Music Listening History

Music listening history will be collected via Spotify by requesting a complete streaming history record for each participant during the study period.

Time frame
14 days
4

Self-Reported Acute Stress

Participants will be instructed to press an "event marker" button on the EmbracePlus sensor device during moments that they feel more stressed than usual.

Time frame
14 days

Secondary outcomes

1

Satisfaction with Study

Participants will be asked to participate in an interview at study completion that asks about their experience, including if the study interfered with their daily life, if they experienced any problems during the study, and overall satisfaction with the study.

Time frame
Within 7 days of completing the study.
2

Time-line followback (TLFB) measure of alcohol use

Participants will be asked about recent alcohol use using a TLFB calendar method at the end-of-study interview.

Time frame
Within 7 days of study completion.
3

Recollections of stressful events

Participants will use a TLFB calendar method to provide recollections of stressful events that occurred during the study.

Time frame
Within 7 days of study completion.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Washington State University

Lead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator